Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results of the RADICALS-RT trial presented by Prof. Chris Parker (The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK), as well as a supportive meta-analysis of 3 trials.
The analysis found no evidence that adjuvant radiotherapy improves event-free survival compared to early salvage radiotherapy.

©2019 - Herts & Essex Urology | Company Reg No: 7205080

Freephone  08000 434353